Non-toxic flakes for authentication of pharmaceutical articles
First Claim
Patent Images
1. A pharmaceutical, nutraceutical, or veterinarian unit-dosage article having a surface, comprising:
- a material selected from the group consisting of a biologically active material and a biologically inert material, and a mixture thereof; and
authentication flakes selected from the group consisting of non-toxic, inorganic optically variable flakes having at least one metallic layer and non-toxic, inorganic taggant flakes;
wherein the authentication flakes are dispersed within the article or on the surface.
4 Assignments
0 Petitions
Accused Products
Abstract
In one embodiment of the present invention, non-toxic inorganic flakes are used for identification and anticounterfeit protection of pharmaceutical articles, such as pills, tablets and capsules, having a core of a biologically active material and/or a biologically inert material. Non-toxic inorganic authentication flakes, either optically variable flakes or taggant flakes having one or more symbols and/or a selected shape are disposed on the surface or inside of the pharmaceutical article.
171 Citations
20 Claims
-
1. A pharmaceutical, nutraceutical, or veterinarian unit-dosage article having a surface, comprising:
- a material selected from the group consisting of a biologically active material and a biologically inert material, and a mixture thereof; and
authentication flakes selected from the group consisting of non-toxic, inorganic optically variable flakes having at least one metallic layer and non-toxic, inorganic taggant flakes;
wherein the authentication flakes are dispersed within the article or on the surface. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
- a material selected from the group consisting of a biologically active material and a biologically inert material, and a mixture thereof; and
-
18. A pharmaceutical, nutraceutical, or veterinarian ointment comprising:
- an ointment base selected from the group consisting of a biologically active material and a biologically inert material, and a mixture thereof; and
authentication flakes selected from the group consisting of non-toxic, inorganic optically variable flakes and non-toxic, inorganic taggant flakes; and
wherein the authentication flakes are dispersed within the ointment base. - View Dependent Claims (19, 20)
- an ointment base selected from the group consisting of a biologically active material and a biologically inert material, and a mixture thereof; and
Specification